Polymer Thin Films for Drug Delivery Process and PAT Development
Keynote SeriesPharmaceutical Technology is sponsoring a sponsoring a Keynote Series session on innovations in solid dosage development and manufacturing on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.
Tuesday, April 26
Innovations in Solid Dosage Development and Manufacturing
Oral solid-dosage forms are the leading drug delivery method, but new development and manufacturing technologies are offering new options for patients. Experts will discuss advances in new solid dosage forms.
1:40–2:10 pm
Polymer Thin Films for Drug Delivery: Process and PAT Development
Polymer thin film is a platform technology for continuous manufacturing, in which in-line monitoring of product quality can be accomplished using various sensing and process analytical technologies, making the technology amenable for real-time release. The robustness of this technology has been demonstrated using multiple BCS Class II drugs, in which particle engineering and design of the film matrix are combined to impart the desired functionality to the final product. This presentation will share results related to the impact of materials and processes on critical quality attributes for film-based drug dosages.
Speaker: Rajesh N. Davé, Distinguished Professor in the Department of Chemical, Biological and Pharmaceutical Engineering, at New Jersey Institute of Technology
To register: http://www.interphex.com/pharmtech
Other presentations in this session:
1–1:30 pm
Drop-On-Demand Manufacturing System for the Flexible Production of Solid Oral Dosage Forms
2:20–2:50 pm
Minitablets: Manufacturing, Characterization Methods and Future Opportunities
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.
